Mefloquine hydrochloride
SIGMA/M2319 - ≥98% (HPLC), powder
Synonym: (AS)
CAS Number: 51773-92-3
Empirical Formula (Hill Notation): C17H17ClF6N2O
Molecular Weight: 414.77
EC Number: 257-412-0
MDL Number: MFCD00797519
Linear Formula: C17H17ClF6N2O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C17H16F6N2O.ClH/c18-16 |
| InChI key | WESWYMRNZNDGBX-YLCXCWDSSA |
| Quality Level | 100 ![]() |
| SMILES string | Cl[H].[H][C@@]1(CCCCN1)[C |
| solubility | DMSO: soluble 38 mg/mL |
| H2O: insoluble | |
| storage condition | desiccated |
| Application: | Mefloquine hydrochloride has been used: • to treat cochlear organotypic cultures with various doses to evaluate its role in cellular pathway involved in apoptosis • in screening for in vitro antischistosomal activity • in cytotoxicity assay of glioblastoma cells |
| Biochem/physiol Actions: | Blocker of gap junction channels Cx36 and Cx50. |
| Biochem/physiol Actions: | Mefloquine is broadly used as an antimalarial drug. It inhibits 80S ribosomes of Plasmodium. It has numerous side effects like anxiety, dizziness, tremor, headache, and hearing loss. Mefloquine damages cochlear and vestibular hair cells through apoptosis. It also damages spiral ganglion neurons, degenerates cortical neuron and disrupts neuronal calcium homeostasis. |
| Packaging: | 100 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| UNSPSC | 12352202 |


